🚀 (1/2) We’re leading a £10m Cancer Data Driven Detection initiative to transform cancer risk assessment and target early detection & prevention more precisely.
Read more: https://t.co/tTSUMS7G8I
@NIHRresearch | @EPSRC | @HDR_UK | @adr_uk | @antonis02
The latest publication from the group, led by Carmen Petitjean and Xin Yang @xinyang6699 on the performance of BOADICEA/CanRisk for breast cancer risk prediction in UKBiobank, out now in @JNCI_Now
Paper: https://t.co/mkMfzogkcM
🧵👇
Latest study on evaluating the multifactorial BOADICEA model, implemented in CanRisk (https://t.co/N60joMS8EB), for predicting 10-year breast cancer risks in the prospective #UKBiobank cohort, from our @antonis02 group, published in @JNCI_Now
https://t.co/yjSjYQMbJZ
Fergus Couch, Antonis Antoniou, Katherine Nathanson, and Tanja Spanic discussed "The Future of Cancer Genetics" in a special #SABCS24 session moderated by Claudine Isaacs.
@antonis02@KLNathanson@TanjaSpanic
📢 UK health data should be recognised as "critical national infrastructure".
Published today, the #SudlowReview offers critical insights into how we can safely and securely use data science to improve health services across the UK.
➡️ Learn more: https://t.co/J8PmVP5mdB
Latest paper from the group on second cancer risks for BRCA1 & BRCA2 pathogenic variant carriers using linked Electronic Health Records, published in @JCO_ASCO
Paper: https://t.co/25X8QgSTmE
Thread 🧵 by lead author @Isaac__Allen 👇
@CRUKresearch@OncoAlert@CRUKCamCentre
Deeply honoured that our team’s and collaborators’ work has been recognised with the 2024 Don Listwin Award. This award reflects the remarkable contribution and dedication of everyone involved in the multidisciplinary work that underpins our cancer risk modelling work.
Delighted to see this paper, led by @fstutzin, out in press today. If you'd like to know more about why and how we updated the results section/report that comes from #CanRisk, you should take a read! https://t.co/5k8GEB2UDm
Latest publication from the group on evaluating the performance of CanRisk / BOADICEA https://t.co/4tfWfx0EmP in predicting ovarian cancer risk
Paper: https://t.co/713KGUeIca
Thread by @xinyang6699 👇
Our latest study @antonis02 on evaluation of the performance of the multifactorial #CanRisk/#BOADICEA model in predicting 10-year ovarian cancer risks in the prospective cohort of #UKBiobank, has now been published with @SpringerNature in @BrJCancer.
https://t.co/UJxTsStzyc
We’re looking for a research associate to develop simulation models for evaluating cancer early detection.
An expert in stochastic modelling? Check out this exciting opportunity @Cambridge_Uni
https://t.co/FJBioDKBOn
We are looking for a Administrative Assistant who will work to provide efficient and effective support to the CCGE Cambridge @Cambridge_Uni
Check out this exciting and flexible opportunity
https://t.co/uLPMLHbQnT
Closes 23 June 2024
The public may wonder about the value of sharing their health data. PREDICT breast and prostate and CanRisk are widely used clinical tools based on NHS data.
https://t.co/PfXDWF6hxU
https://t.co/HPJXStFWxv
https://t.co/GMlUGcH94u
These would not be possible without data sharing.
Latest paper from the group: On risks of second cancers in female and male breast cancer survivors, using linked EHR data on ~600,000 patients in England. In @lancetRH_Europe
https://t.co/nBX03rqLBn
Expertly led by @Isaac__Allen for his PhD @CRUKresearch https://t.co/eNUaNyxgC9
Followed a co-design approach with public, patients & healthcare professionals expertly led by @fstutzin Tim Carver & @Stephthepsych. Funding: @CRUKresearch
📣 New revamped version of CanRisk https://t.co/4tfWfx0EmP now released.
Includes re-designed cancer risk assessment results section & new report for improved cancer risk communication to public/patients by healthcare professionals. Available in 7 languages
#gcchat@OncoAlert